approved glp 1 agonists Patient education tips for GLP-1, weight loss drug treatment Frontiers | GLP−1 receptor agonists
Description
Therefore, its a highly attractive target for type 2 diabetes (T2D) therapy
In addition to the effect on food intake reduction and glucose-stimulated insulin secretion, GLP-1 also acts to delay gastric emptying therefore aiding satiety and glycaemic control (42)
doi:10.1038/nrneurol.2017.99 58
36 Dapagliflozin EMA product information (2023)
Glucagon-like peptide-1 Glucagon-like peptide-1 ( GLP-1 ) is a 30- or 31-amino-acid-long peptide hormone deriving from tissue-specific posttranslational processing of the proglucagon peptide
Mobile Phones Only) For more information, please visit DISCLAIMER : BioMedWire (BMW) is the source of the Article and content set forth above
